Back
BioNTech SE Quote, Financials, Valuation and Earnings
Sponsored
BNTX
Sponsored
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Buy
55
BNTX
BioNTech SE
Last Price:
110.90
Seasonality Move:
0.73%
7 Day Trial
ALL ACCESS PASS
$
7
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.BioNTech SE Price Quote
$110.90
+0.02 (+-0.61%)
(Updated: October 23, 2024 at 5:03 AM ET)
BioNTech SE Key Stats
Buy
55
BioNTech SE (BNTX)
is a Buy
Day range:
$109.59 - $111.89
52-week range:
$76.53 - $131.49
Dividend yield:
0%
P/E ratio:
26.74
P/S ratio:
9.15
P/B ratio:
1.29%
Volume:
358.7K
Avg. volume:
1.2M
1-year change:
21.97%
Market cap:
$26.4B
Revenue:
$4.1B
EPS:
$-2.28
How Much Does BioNTech SE Make?
-
How Much Are BioNTech SE's Sales Annually?
BNTX Revenues are $4.1B -
How Much Profit Does BioNTech SE's Make A Year?
BNTX net income is $1B
Is BioNTech SE Growing As A Company?
-
What Is BioNTech SE's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.24% -
What Is BioNTech SE's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
BioNTech SE Stock Price Performance
-
Did BioNTech SE Stock Go Up Last Month?
BioNTech SE share price went down by -1.25% last month -
Did BNTX's Share Price Rise Over The Last Year?
BNTX share price rose by 21.97% over the past 1 year
What Is BioNTech SE 52-Week High & Low?
-
What Is BioNTech SE’s 52-Week High Share Price?
BioNTech SE has traded as high as $131.49 over the past 52 weeks -
What Is BioNTech SE’s 52-Week Low Share Price?
BioNTech SE has traded as low as $76.53 over the past 52 weeks
BioNTech SE Price To Free Cash Flow
-
Is BioNTech SE Stock Overvalued?
BioNTech SE is trading at a price to free cash flow ratio of 10.59 -
Is BioNTech SE Stock Undervalued?
BioNTech SE EV to Free Cash Flow ratio is 3.22 -
What Is BioNTech SE’s Price Earnings Growth Ratio?
BNTX PEG ratio is 0.00 -
Is BioNTech SE Trading At A Premium To Earnings?
BioNTech SE EV to EBIT ratio is 0.00
Is It Risky To Buy BioNTech SE?
-
How Much Debt Does BioNTech SE Have?
Total long term debt quarterly is $272.9M -
How Much Cash Does BioNTech SE Have?
Cash and short term investments quarterly total is $18.5B -
What Is BioNTech SE’s Book Value Per Share?
Book value per share is 85.98
Is BioNTech SE Cash Flow Positive?
-
What Is BNTX Cash Flow From Operations?
Cash flow from operations (TTM) is $3.2B -
What Is BioNTech SE’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$380.2M -
What Is BioNTech SE’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$7B
BioNTech SE Return On Invested Capital
-
Is Management Doing A Good Job?
BNTX return on invested capital is -2.51% -
What Is BioNTech SE Return On Assets?
ROA measures how assets are converting to revenues and is -2.25% -
What Is BNTX Return On Equity?
ROE is a measure of profitability and is -2.54%
BioNTech SE Earnings Date & Stock Price
-
What Is BioNTech SE's Stock Price Today?
A single share of BNTX can be purchased today for 110.88 -
What Is BioNTech SE’s Stock Symbol?
BioNTech SE trades on the nasdaq under the ticker symbol: BNTX -
When Is BioNTech SE’s Next Earnings Date?
The next quarterly earnings date for BioNTech SE is scheduled on November 6, 2024 -
When Is BNTX's next ex-dividend date?
BioNTech SE's next ex-dividend date is June 2, 2022 -
How To Buy BioNTech SE Stock?
You can buy BioNTech SE shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BioNTech SE Competitors
-
Who Are BioNTech SE's Competitors?
Below is a list of companies who compete with BioNTech SE or are related in some way:
BioNTech SE Dividend Yield
-
What Is BNTX Dividend Yield?
BioNTech SE’s dividend yield currently is 0% -
What Is BioNTech SE’s Payout Ratio?
BioNTech SE’s payout ratio is 0% -
When Did BioNTech SE Last Pay A Dividend?
The latest dividend pay date is October 23, 2024 -
What Is BioNTech SE’s Dividend Per Share?
BioNTech SE pays a dividend of $0.00 per share
BioNTech SE Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -65.76% |
Revenue: | -24.22% | -4.39% |
Analyst Recommendations
Buy Recommendations: | 8 |
---|---|
Hold Recommendations: | 6 |
Sell Recommendations: | 1 |
Price Target: | 129.08 |
Upside from Last Price: | 16.41% |